UBS Group’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-7,000
Closed -$544K 9227
2023
Q4
$544K Sell
7,000
-5,700
-45% -$422K ﹤0.01% 5043
2023
Q3
$893K Hold
12,700
﹤0.01% 4182
2023
Q2
$1.01M Buy
12,700
+7,000
+123% +$506K ﹤0.01% 4232
2023
Q1
$412K Hold
5,700
﹤0.01% 4843
2022
Q4
$469K Buy
+5,700
New +$470K ﹤0.01% 4762
2015
Q1
Sell
-400
Closed -$24K 8717
2014
Q4
$24K Buy
+400
New +$23.3K ﹤0.01% 7364

Other funds holding ACHC

UBS Group's ACHC Position: Q1 2026 in Review

UBS Group increased its Acadia Healthcare (ACHC) stake by 43% in Q1 2026, buying an estimated $15.5M and bringing the position to 2,833,862 shares worth $66.3M. The position accounts for 0.01% of the portfolio, ranked #1364.

UBS Group first reported a position in ACHC in Q4 2014 and has held it in 46 quarters since. The position peaked at $107M in Q3 2025. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

  • UBS Group held 2,833,862 shares of Acadia Healthcare worth $66.3M as of Q1 2026.
  • UBS Group bought 855,771 Acadia Healthcare shares in Q1 2026, an estimated $15.5M.
  • Acadia Healthcare made up 0.01% of UBS Group's portfolio in Q1 2026, its #1364 holding.
  • UBS Group first reported a position in Acadia Healthcare in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Acadia Healthcare position peaked at $107M in Q3 2025.
  • 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.